Quick Answer
OKYO Pharma Ltd reported Total Assets of $3.68 million for fiscal year 2025.
OKYO Pharma Ltd — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $3.68M +138.6% |
$1.54M -70.4% |
$5.20M +21.0% |
$4.30M -39.4% |
$7.09M | — |
| R&D Expense | $2.25M -72.7% |
$8.24M +30.1% |
$6.34M +293.8% |
$1.61M +362.1% |
$348.3K -32.8% |
$518.1K |
- OKYO Pharma Ltd reported Total Assets of $3.68 million for fiscal year 2025.
- OKYO Pharma Ltd showed an increase of +138.6% in Total Assets compared to the prior fiscal year.
- OKYO Pharma Ltd reported R&D Expense of $2.25 million for fiscal year 2025.
- OKYO Pharma Ltd showed a decrease of -72.7% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: